The proportion of monoclonal antibody has been increasing, and the drug target of monoclonal antibody has been gradually diversified. In addition to the traditional cell surface antigens, common cytokines are included. Kemwell Biopharma Pvt Ltd is a pure play mabs stability studies service provider for biopharmaceuticals.
Kemwell has signed a contract to manufacture and supply drug substance with it’s state-of-art mammalian cell culture for Phase 3 clinical trials, conducted by the US. Read more.
Kemwell Biopharma provides the customized process, product development and manufacturing solutions to pharmaceutical and biopharmaceutical organizations worldwid...
